Cas9

Michael V Zuccaro1, Jia Xu2, Carl Mitchell3

  • 1Department of Pediatrics and Naomi Berrie Diabetes Center, Columbia University, New York, NY 10032, USA; Columbia University Stem Cell Initiative, New York, NY 10032, USA.

Cell
|October 30, 2020
PubMed
概括

人类胚胎中的基因编辑可以纠正导致遗传性疾病的突变. 然而,这项研究显示,常见的修复机制会导致意外的染色体损失和缺陷,这对安全的临床应用构成重大挑战.